Distinguished in Obstructive Sleep Apnea

Dr. Daniel Norman

Pulmonary Medicine
Providence
12301 Wilshire Boulevard, Suite 200, 
Los Angeles, CA 
Accepting New Patients
Offers Telehealth

Distinguished in Obstructive Sleep Apnea
Providence
12301 Wilshire Boulevard, Suite 200, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Norman is a Pulmonary Medicine provider in Los Angeles, California. Dr. Norman is rated as a Distinguished provider by MediFind in the treatment of Obstructive Sleep Apnea. His top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Excessive Daytime Sleepiness, and Narcolepsy. Dr. Norman is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles and participated in 4 clinical trials in the study of Obstructive Sleep Apnea.

Specialties
Pulmonary Medicine
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

12301 Wilshire Boulevard, Suite 200, Los Angeles, CA 90025
Call: 310-828-2293

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Enrollment Status: Active_not_recruiting
Publish Date: October 22, 2025
Intervention Type: Drug
Study Drug: Pitolisant
Study Phase: Phase 2
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Open-Label 4-Period Dose-Escalation Safety and Efficacy Study of AD313 in Participants With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: April 07, 2023
Intervention Type: Drug
Study Drugs: Atomoxetine, AD313
Study Phase: Phase 1/Phase 2
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Phase 2, Placebo-Controlled, Parallel Group Dose-Finding Study to Evaluate the Efficacy and Safety of Three Dose Levels of AD036 in Adults With Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Phase: Phase 2
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug
Study Drugs: AD109, AD504, Atomoxetine Hydrochloride
Study Phase: Phase 2
Evaluation of Novel Proprietary Biometric as an Aid in the Screening and Diagnosis of Sleep Breathing Disorders
Evaluation of Novel Proprietary Biometric as an Aid in the Screening and Diagnosis of Sleep Breathing Disorders
Enrollment Status: Terminated
Publish Date: February 26, 2019
View 8 Less Clinical Trials

4 Total Publications

Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study.
Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study.
Journal: Thorax
Published: September 27, 2024
View All 4 Publications
Similar Doctors
Elite in Obstructive Sleep Apnea
Dr. Ravi S. Aysola
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Elite in Obstructive Sleep Apnea
Dr. Ravi S. Aysola
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

The Regents Of The University Of California

2020 Santa Monica Blvd, Suite 210, 
Santa Monica, CA 
 (1.1 miles away)
310-458-2381
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ravi Aysola is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Santa Monica, California. Dr. Aysola is rated as a Distinguished provider by MediFind in the treatment of Obstructive Sleep Apnea. His top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Excessive Daytime Sleepiness, and Periodic Limb Movement Disorder.

Elite in Obstructive Sleep Apnea
Dr. Richard J. Castriotta
Pulmonary Medicine | Sleep Medicine
Elite in Obstructive Sleep Apnea
Dr. Richard J. Castriotta
Pulmonary Medicine | Sleep Medicine

USC Care Medical Group Inc

1520 San Pablo St, Fl 4, 
Los Angeles, CA 
 (15.3 miles away)
800-872-2273
Languages Spoken:
English
See accepted insurances

Richard Castriotta is a Pulmonary Medicine specialist and a Sleep Medicine provider in Los Angeles, California. Dr. Castriotta is rated as a Distinguished provider by MediFind in the treatment of Obstructive Sleep Apnea. His top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Insomnia, Acute Interstitial Pneumonia, and Adenoidectomy.

Distinguished in Obstructive Sleep Apnea
Dr. Michelle R. Zeidler
Pulmonary Medicine
Distinguished in Obstructive Sleep Apnea
Dr. Michelle R. Zeidler
Pulmonary Medicine

The Regents Of The University Of California

200 Medical Plaza, 
Los Angeles, CA 
 (2.0 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michelle Zeidler is a Pulmonary Medicine provider in Los Angeles, California. Dr. Zeidler is rated as an Advanced provider by MediFind in the treatment of Obstructive Sleep Apnea. Her top areas of expertise are Obstructive Sleep Apnea, Central Sleep Apnea, Cerebral Hypoxia, and Chronic Obstructive Pulmonary Disease (COPD).

VIEW MORE OBSTRUCTIVE SLEEP APNEA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Norman's expertise for a condition
ConditionClose
    • Distinguished
    • Obstructive Sleep Apnea
      Dr. Norman is
      Distinguished
      . Learn about Obstructive Sleep Apnea.
      See more Obstructive Sleep Apnea experts
    • Advanced
    • Central Sleep Apnea
      Dr. Norman is
      Advanced
      . Learn about Central Sleep Apnea.
      See more Central Sleep Apnea experts
    • Excessive Daytime Sleepiness
      Dr. Norman is
      Advanced
      . Learn about Excessive Daytime Sleepiness.
      See more Excessive Daytime Sleepiness experts
    • Experienced
    • Idiopathic Hypersomnia
      Dr. Norman is
      Experienced
      . Learn about Idiopathic Hypersomnia.
      See more Idiopathic Hypersomnia experts
    • Irregular Sleep-Wake Syndrome
      Dr. Norman is
      Experienced
      . Learn about Irregular Sleep-Wake Syndrome.
      See more Irregular Sleep-Wake Syndrome experts
    • Narcolepsy
      Dr. Norman is
      Experienced
      . Learn about Narcolepsy.
      See more Narcolepsy experts
    • Paracoccidioidomycosis
      Dr. Norman is
      Experienced
      . Learn about Paracoccidioidomycosis.
      See more Paracoccidioidomycosis experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.